Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: ASKgene pharm, Inc ×

ASKgene pharm, Inc

This funder is selected. Its supporting articles are shown below.

ASKgene pharm, Inc1

Articles mentioning ASKgene pharm, Inc

1 articles · page 1 of 1

616 Initial safety and efficacy results from a first in human, phase 1/2 study of ASKG915, an anti-PD-1/Pro-IL-15 bifunctional fusion protein, for patients with advanced solid tumors

jitc · abstract · 2025-11-04 · 1 matching annotations

80.8%

ASKgene pharm, Inc ASKG915 cervical cancer NSCLC ovarian cancer colorectal cancer MSS CRC ASKG915-related advanced solid tumors

…sonnel for their support of this trial. The study was funded by ASKgene pharm, Inc.Trial Registration Clinical trial information: NCT05867420Ethic…

Browse funders

ASKgene pharm, Inc

Articles mentioning ASKgene pharm, Inc

616 Initial safety and efficacy results from a first in human, phase 1/2 study of ASKG915, an anti-PD-1/Pro-IL-15 bifunctional fusion protein, for patients with advanced solid tumors